{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:35:28Z","timestamp":1792377328216,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52222307"],"award-info":[{"award-number":["52222307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20230204086YY"],"award-info":[{"award-number":["20230204086YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biomaterials.2025.123462","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:35:54Z","timestamp":1748831754000},"page":"123462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Biomaterial-based therapeutic strategies for inflammatory bowel disease"],"prefix":"10.1016","volume":"324","author":[{"given":"Wei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-5208","authenticated-orcid":false,"given":"Qiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-4146","authenticated-orcid":false,"given":"Chunsheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biomaterials.2025.123462_bib1","first-page":"648","article-title":"Inflammatory bowel disease goes global","volume":"319","author":"Friedrich","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123462_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China","volume":"1","author":"Kaplan","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123462_bib3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123462_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/1751-2980.12994","article-title":"Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing)","volume":"22","year":"2021","journal-title":"J Dig Dis"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S2468-1253(16)30111-X","article-title":"Genetics of inflammatory bowel disease: beyond <em>NOD2<\/em&gt","volume":"2","author":"Mirkov","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.3761","article-title":"Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7","volume":"49","author":"Luo","year":"2017","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123462_bib7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.cgh.2014.04.021","article-title":"Sleep duration affects risk for ulcerative colitis: a prospective cohort study","volume":"12","author":"Ananthakrishnan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123462_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cgh.2013.01.021","article-title":"Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis","volume":"11","author":"Ananthakrishnan","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123462_bib9","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.3390\/ijms22063076","article-title":"The interplay between immune system and microbiota in inflammatory bowel disease: a narrative review","volume":"22","author":"Aldars-Garc\u00eda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123462_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ibd.20903","article-title":"Low counts of Faecalibacterium prausnitzii in colitis microbiota","volume":"15","author":"Sokol","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123462_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123462_bib12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/ph6101322","article-title":"Loss of response to long-term infliximab therapy in children with Crohn's disease","volume":"6","author":"Gouldthorpe","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00595-013-0538-0","article-title":"Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study","volume":"44","author":"Araki","year":"2014","journal-title":"Surg. Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123462_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MIB.0000000000000202","article-title":"Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse","volume":"21","author":"Papamichael","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123462_bib15","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis","volume":"365","author":"Danese","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2025.123462_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.02.028","article-title":"Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment","volume":"345","author":"Wang","year":"2022","journal-title":"J. Contr. Release"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123462_bib17","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.3748\/wjg.v27.i23.3317","article-title":"Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?","volume":"27","author":"Nishida","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123462_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123462_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113079","article-title":"Pathological features-based targeted delivery strategies in IBD therapy: a mini review","volume":"151","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms4020020","article-title":"Microbiome, metabolome and inflammatory bowel disease","volume":"4","author":"Ahmed","year":"2016","journal-title":"Microorganisms"},{"issue":"39","key":"10.1016\/j.biomaterials.2025.123462_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204650","article-title":"Bionic regulators break the ecological niche of pathogenic bacteria for modulating dysregulated microbiome in colitis","volume":"34","author":"Yang","year":"2022","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123462_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309972","article-title":"A gas therapy strategy for intestinal flora regulation and colitis treatment by nanogel-based multistage NO delivery microcapsules","volume":"36","author":"Fu","year":"2024","journal-title":"Adv. Mater."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123462_bib23","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3748\/wjg.v29.i14.2078","article-title":"Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives","volume":"29","author":"Roy","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123462_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5217\/ir.2023.00085","article-title":"The practice of fecal microbiota transplantation in inflammatory bowel disease","volume":"22","author":"Arora","year":"2024","journal-title":"Int. Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123462_bib25","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/00365521.2017.1347812","article-title":"The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease","volume":"52","author":"Khajah","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2025.123462_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213002","article-title":"Chitosan-modified Phellinus igniarius polysaccharide PLGA nanoparticles ameliorated inflammatory bowel disease","volume":"139","author":"Bai","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.biomaterials.2025.123462_bib27","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ijbiomac.2021.05.200","article-title":"Ramulus mori polysaccharide-loaded PLGA nanoparticles and their anti-inflammatory effects in vivo","volume":"182","author":"Feng","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123462_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060919","article-title":"Potential benefits of dietary fibre intervention in inflammatory bowel disease","volume":"17","author":"Wong","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123462_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9621668","article-title":"Inflammatory bowel disease therapeutics: a focus on probiotic engineering","volume":"2022","author":"Mishra","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biomaterials.2025.123462_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/5584_2018_319","article-title":"Probiotics in the treatment of inflammatory bowel disease","volume":"1125","author":"Guandalini","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123462_bib31","first-page":"1759","article-title":"Probiotics: the scientific evidence in the context of inflammatory bowel disease","volume":"57","author":"Celiberto","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biomaterials.2025.123462_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105140","article-title":"Oral administration of pasteurized probiotic fermented milk alleviates dextran sulfate sodium-induced inflammatory bowel disease in rats","volume":"94","author":"Feng","year":"2022","journal-title":"J. Funct.Foods"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031238","article-title":"Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR \u03b3 to suppress colitis","volume":"7","author":"Bassaganya-Riera","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123462_bib34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.12998\/wjcc.v8.i8.1361","article-title":"Probiotic mixture VSL#3: an overview of basic and clinical studies in chronic diseases","volume":"8","author":"Cheng","year":"2020","journal-title":"World J. Clin. Cases"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib35","article-title":"Probiotics for maintenance of remission in ulcerative colitis","author":"Iheozor-Ejiofor","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123462_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202113034","article-title":"Poly-\u03b3-Glutamic acid microgel-encapsulated probiotics with gastric acid resistance and smart inflammatory factor targeted delivery performance to ameliorate colitis","volume":"32","author":"Wang","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122274","article-title":"Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota","volume":"301","author":"Huang","year":"2023","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10219","article-title":"An engineered probiotic secreting Sj16 ameliorates colitis via ruminococcaceae\/butyrate\/retinoic acid axis","volume":"6","author":"Wang","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123462_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308728","article-title":"Responsively degradable nanoarmor-assisted super resistance and stable colonization of probiotics for enhanced inflammation-targeted delivery","volume":"36","author":"Zhu","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123462_bib40","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123462_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","article-title":"Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?","volume":"19","author":"Villablanca","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123462_bib42","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","article-title":"Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review","volume":"14","author":"Colombel","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Fr\u00f8slie","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2025.123462_bib46","first-page":"251","article-title":"GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease","volume":"19","author":"Mao","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biomaterials.2016.06.018","article-title":"Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer","volume":"101","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123462_bib48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2007.10.026","article-title":"PepT1-Mediated tripeptide KPV uptake reduces intestinal inflammation","volume":"134","author":"Dalmasso","year":"2008","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123462_bib49","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acsptsci.9b00016","article-title":"The discovery of GLP-2 and development of teduglutide for short bowel syndrome","volume":"2","author":"Drucker","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123462_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nbt0797-673","article-title":"Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV","volume":"15","author":"Drucker","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2025.123462_bib52","first-page":"206","article-title":"A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment","volume":"32","author":"Marotti","year":"2024","journal-title":"Bioact. Mater."},{"issue":"Pt 2","key":"10.1016\/j.biomaterials.2025.123462_bib53","article-title":"Self-crosslinking hyaluronic acid hydrogel as an enteroprotective agent for the treatment of inflammatory bowel disease","volume":"273","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123462_bib54","article-title":"Orally administrable H(2) S-Scavenging metal-organic framework prepared by Co-Flow microfluidics for comprehensive restoration of intestinal milieu","volume":"35","author":"Dou","year":"2023","journal-title":"Adv. Mater."},{"issue":"7871","key":"10.1016\/j.biomaterials.2025.123462_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-021-03785-9","article-title":"Microbes exploit death-induced nutrient release by gut epithelial cells","volume":"596","author":"Anderson","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib56","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/j.gastro.2011.05.032","article-title":"p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis","volume":"141","author":"Dirisina","year":"2011","journal-title":"Gastroenterology"},{"issue":"49","key":"10.1016\/j.biomaterials.2025.123462_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309370","article-title":"Precisely inhibiting excessive intestinal epithelial cell apoptosis to efficiently treat inflammatory bowel disease with oral Pifithrin-\u03b1 embedded nanomedicine (OPEN)","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib58","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.biomaterials.2010.09.034","article-title":"Oral nuclear factor-\u03baB decoy oligonucleotides delivery system with chitosan modified poly(d,l-lactide-co-glycolide) nanospheres for inflammatory bowel disease","volume":"32","author":"Tahara","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123462_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biomaterials.2018.07.044","article-title":"In situ self-spray coating system that can uniformly disperse a poorly water-soluble H2S donor on the colorectal surface to treat inflammatory bowel diseases","volume":"182","author":"Lin","year":"2018","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123462_bib60","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1039\/D2FO04029H","article-title":"The synergistic effect of epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on inflammatory bowel disease","volume":"14","author":"Hu","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.biomaterials.2025.123462_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121364","article-title":"Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease","volume":"281","author":"Kotla","year":"2022","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib62","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.biomaterials.2010.09.034","article-title":"Oral nuclear factor-\u03baB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease","volume":"32","author":"Tahara","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123462_bib63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.biomaterials.2018.09.024","article-title":"Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine","volume":"185","author":"Li","year":"2018","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123462_bib64","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ecco-jcc\/jjab033","article-title":"Therapeutic potential of a self-assembling peptide hydrogel to treat colonic injuries associated with inflammatory bowel disease","volume":"15","author":"Araki","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"49","key":"10.1016\/j.biomaterials.2025.123462_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202304381","article-title":"Reactive oxygen species-activated CO versatile nanomedicine with innate gut immune and microbiome remodeling effects for treating inflammatory bowel disease","volume":"33","author":"Zeng","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123462_bib66","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/acs.chemmater.8b01173","article-title":"Rational design of polyphenol-poloxamer nanovesicles for targeting inflammatory bowel disease therapy","volume":"30","author":"Wang","year":"2018","journal-title":"Chem. Mater."},{"issue":"300","key":"10.1016\/j.biomaterials.2025.123462_bib67","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"sup2","key":"10.1016\/j.biomaterials.2025.123462_bib68","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/21691401.2018.1463232","article-title":"Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease","volume":"46","author":"Sinhmar","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.biomaterials.2025.123462_bib69","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.carbpol.2016.07.021","article-title":"Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment","volume":"152","author":"Md Ramli","year":"2016","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123462_bib70","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12951-023-02097-6","article-title":"Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment","volume":"21","author":"Qiu","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"28","key":"10.1016\/j.biomaterials.2025.123462_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301192","article-title":"Pollen-inspired adhesive multilobe microparticles from microfluidics for intestinal drug delivery","volume":"35","author":"Huang","year":"2023","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123462_bib72","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1021\/acsami.4c05214","article-title":"The role of nanoparticle morphology on enhancing delivery of budesonide for treatment of inflammatory bowel disease","volume":"16","author":"Li","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2025.123462_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2018.09.005","article-title":"Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease","volume":"185","author":"Date","year":"2018","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123462_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202211644","article-title":"Oral administration of multistage albumin nanomedicine depots (MANDs) for targeted efficient alleviation of chronic inflammatory diseases","volume":"33","author":"Zhang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121178","article-title":"'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases","volume":"279","author":"Zu","year":"2021","journal-title":"Biomaterials"},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123462_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202100548","article-title":"Oligoethyleneimine-conjugated hyaluronic acid modulates inflammatory responses and enhances therapeutic efficacy for ulcerative colitis","volume":"31","author":"Nishiguchi","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123462_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202305042","article-title":"Anion-dependent layered double hydroxide nanoparticles regulate differentiation of CD206+ CX3CR1+ macrophages by inhibiting the IL-17 signaling pathway contributing to inflammatory bowel disease","volume":"34","author":"Niu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202107433","article-title":"GeTe nanosheets as Theranostic agents for multimodal imaging and therapy of inflammatory bowel disease","volume":"32","author":"Song","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123462_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202212566","article-title":"Hydrogel-based artificial mucosa restores local immune and microbial homeostasis for treating ulcerative colitis","volume":"33","author":"Wen","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122254","article-title":"Atmosphere-inspired multilayered nanoarmor with modulable protection and delivery of Interleukin-4 for inflammatory microenvironment modulation","volume":"301","author":"Ge","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123462_bib81","first-page":"272","article-title":"Self-adaptive pyroptosis-responsive nanoliposomes block pyroptosis in autoimmune inflammatory diseases","volume":"36","author":"Xu","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123462_bib82","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200919R","article-title":"The novel sustained 3-hydroxybutyrate donor poly-D-3-hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T-cells","volume":"37","author":"Suzuki","year":"2023","journal-title":"Faseb j"},{"key":"10.1016\/j.biomaterials.2025.123462_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122584","article-title":"Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery","volume":"309","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123462_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118556","article-title":"Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease","volume":"273","author":"Li","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biomaterials.2025.123462_bib85","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.actbio.2021.12.015","article-title":"Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease","volume":"140","author":"Shrestha","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib86","first-page":"138","article-title":"Oral TNF-\u03b1 siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease","volume":"34","author":"Han","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biomaterials.2015.01.013","article-title":"An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease","volume":"48","author":"Huang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123462_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121468","article-title":"An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT\/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome","volume":"283","author":"Sun","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123462_bib89","first-page":"433","article-title":"Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy","volume":"18","author":"Yoon","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib90","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.2147\/IJN.S378073","article-title":"Oral administration of therapeutic enzyme capsule for the management of inflammatory bowel disease","volume":"17","author":"Liang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123462_bib91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.biomaterials.2016.08.010","article-title":"A superoxide dismutase\/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease","volume":"105","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.biomaterials.2025.123462_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301585","article-title":"Efficient therapy of inflammatory bowel disease (IBD) with highly specific and durable targeted Ta(2) C modified with chondroitin sulfate (TACS)","volume":"35","author":"Song","year":"2023","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123462_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207890","article-title":"Probiotic-inspired nanomedicine restores intestinal homeostasis in colitis by regulating redox balance, immune responses, and the gut microbiome","volume":"35","author":"Xu","year":"2023","journal-title":"Adv. Mater."},{"issue":"38","key":"10.1016\/j.biomaterials.2025.123462_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202402781","article-title":"DNA nanostructures treat inflammatory bowel disease through ROS scavenging and gut microbiota modulation","volume":"34","author":"Ge","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"33","key":"10.1016\/j.biomaterials.2025.123462_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202316227","article-title":"Intestine-targeted controlled hydrogen-releasing MgH2 microcapsules for improving the mitochondrial metabolism of inflammatory bowel disease","volume":"34","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"28","key":"10.1016\/j.biomaterials.2025.123462_bib96","doi-asserted-by":"crossref","first-page":"33273","DOI":"10.1021\/acsami.3c03332","article-title":"Mn(3)O(4) nanozyme loaded thermosensitive PDLLA-PEG-PDLLA hydrogels for the treatment of inflammatory bowel disease","volume":"15","author":"Yang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123462_bib97","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.7150\/thno.33727","article-title":"Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2025.123462_bib98","first-page":"167","article-title":"Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease","volume":"35","author":"Shi","year":"2024","journal-title":"Bioact. Mater."},{"issue":"27","key":"10.1016\/j.biomaterials.2025.123462_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202201101","article-title":"A valence-engineered self-cascading antioxidant nanozyme for the therapy of inflammatory bowel disease","volume":"61","author":"Wang","year":"2022","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"45","key":"10.1016\/j.biomaterials.2025.123462_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202004692","article-title":"An orally administered CeO2@Montmorillonite nanozyme targets inflammation for inflammatory bowel disease therapy","volume":"30","author":"Zhao","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib101","first-page":"95","article-title":"Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease","volume":"25","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121392","article-title":"SHARP hydrogel for the treatment of inflammatory bowel disease","volume":"613","author":"Pol\u00e1kov\u00e1","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"45","key":"10.1016\/j.biomaterials.2025.123462_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202305133","article-title":"Nanoassemblies derived from natural flavonoid compounds as new antioxidant oral preparations for targeted inflammatory bowel disease therapy","volume":"33","author":"Tang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123462_bib104","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.actbio.2023.08.020","article-title":"An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease","volume":"169","author":"Zhang","year":"2023","journal-title":"Acta Biomater."},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123462_bib105","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1021\/acsnano.4c00830","article-title":"Polyphenolic nanoparticle-modified probiotics for microenvironment remodeling and targeted therapy of inflammatory bowel disease","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123462_bib106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6882-10-13","article-title":"Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)","volume":"10","author":"Matthes","year":"2010","journal-title":"BMC Compl. Alternative Med."},{"issue":"50","key":"10.1016\/j.biomaterials.2025.123462_bib107","article-title":"pH and reactive oxygen species-sequential responsive nano-in-micro composite for targeted therapy of inflammatory bowel disease","volume":"28","author":"Bertoni","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib108","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s13346-018-0512-x","article-title":"Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects","volume":"9","author":"Sohail","year":"2019","journal-title":"Drug Deliv Transl Res"},{"issue":"300","key":"10.1016\/j.biomaterials.2025.123462_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123462_bib110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/10837450.2011.653819","article-title":"Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease","volume":"18","author":"Patel","year":"2013","journal-title":"Pharmaceut. Dev. Technol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225003813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225003813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:43:47Z","timestamp":1778766227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225003813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":110,"alternative-id":["S0142961225003813"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123462","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterial-based therapeutic strategies for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123462"}}